Following our call to join in the discussion over the suitability of implementing a reporting checklist for bio–nano papers, the community responds.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Reproducibility in research into metal-organic frameworks in nanomedicine
Communications Materials Open Access 05 April 2024
-
Cancer nanomedicine: emergence, expansion, and expectations
SN Applied Sciences Open Access 12 December 2023
-
Too advanced for assessment? Advanced materials, nanomedicine and the environment
Environmental Sciences Europe Open Access 16 August 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
29 July 2019
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
09 July 2019
An amendment to this paper has been published and can be accessed via a link at the top of the paper
References
Wilhelm, S. et al. Nat. Rev. Mater. 1, 16014 (2016).
Leong, H. S. et al. Nat. Protoc. 5, 1406–1417 (2010).
Townson, J. L. et al. J. Am. Chem. Soc. 135, 16030–16033 (2013).
Dogra, P. et al. Nat. Commun. 9, 4551 (2018).
Cho, C.-F., Ablack, A., Leong, H.-S., Zijlstra, A. & Lewis, J. J. Vis. Exp. https://doi.org/10.3791/2808 (2011).
Durfee, P. N. et al. ACS Nano 10, 8325–8345 (2016).
FDA’s Approach to Regulation of Nanotechnology Products (FDA, 2018); https://www.fda.gov/scienceresearch/specialtopics/nanotechnology/ucm301114.htm
Swierczewska, M., Crist, R. M. & McNeil, S. E. Methods Mol. Biol. 1682, 3–16 (2018).
Crist, R. M. et al. Integr. Biol. 5, 66–73 (2013).
Gioria, S. et al. Nanomedicine https://doi.org/10.2217/nnm-2017-0338 (2018).
Caputo, F. et al. J. Control. Release 299, 31–43 (2019).
Prina-Mello, A. in Handbook of Nanomaterials for Cancer Theranostics (ed. Conde, J.) Ch. 17 (Elsevier, 2018).
Adiseshaiah, P. P. & Stern, S. T. Methods Mol. Biol. 1682, 241–253 (2018).
Nat. Nanotechnol. 13, 765 (2018).
Faria, M. et al. Nat. Nanotechnol. 13, 777–785 (2018).
Bouwmeester, H. et al. Nanotoxicology 5, 1–11 (2011).
Nat. Nanotechnol. 7, 545 (2012).
Pettitt, M. E. & Lead, J. R. Environ. Int. 52, 41–50 (2013).
Nat. Nanotechnol. 8, 69 (2013).
Schrurs, F. & Lison, D. Nat. Nanotechnol. 7, 546–548 (2012).
Nel, A. E. et al. ACS Nano 9, 5627–5630 (2015).
Zhang, H. et al. ACS Nano 6, 4349–4368 (2012).
Li, R. et al. ACS Nano 8, 1771–1783 (2014).
Li, R. et al. ACS Nano 12, 1390–1402 (2018).
Liu, X. et al. J. Clin. Invest. 127, 2007–2018 (2017).
“Definitions in Biomaterials” Conference Attracts World Experts to Chengdu, China (Society for Biomaterials, 7 January 2018); https://www.biomaterials.org/sites/default/files/docs/2018/biomaterials_definitions_conference_press_release.pdf
Clotilde, T. et al. J. Extracell. Vesicles 7, 1535750 (2018).
EV-TRACK Consortium. Nat. Methods 14, 228–232 (2017).
Acknowledgements
Kimberly S. Butler, Hon S. Leong and C. Jeffrey Brinker: Sandia National Laboratories is a multi-mission laboratory managed and operated by National Technology and Engineering Solutions of Sandia, LLC, a wholly owned subsidiary of Honeywell International, Inc., for the US Department of Energy’s National Nuclear Security Administration under contract DENA0003525. Any subjective views or opinions that might be expressed in the paper do not necessarily represent the views of the US Department of Energy or the US government.
Adriele Prina-Mello, Ruth Schmid, Peter Wick, Fanny Caputo, Patrick Boisseau, Rachael M. Crist and Scott E. McNeil: the view expressed in this Correspondence is reflective of the European Nanomedicine Characterisation Laboratory (EUNCL EC-H2020 ref. 654190) and the REFINE consortium (REFINE EC-H2020 ref. 761104). The work of authors Rachael M. Crist and Scott E. McNeil has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.
Author information
Authors and Affiliations
Corresponding author
Supplementary Information
Rights and permissions
About this article
Cite this article
Leong, H.S., Butler, K.S., Brinker, C.J. et al. On the issue of transparency and reproducibility in nanomedicine. Nat. Nanotechnol. 14, 629–635 (2019). https://doi.org/10.1038/s41565-019-0496-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-019-0496-9
This article is cited by
-
Reproducibility in research into metal-organic frameworks in nanomedicine
Communications Materials (2024)
-
Nanomaterial-based contrast agents
Nature Reviews Methods Primers (2023)
-
The protein corona from nanomedicine to environmental science
Nature Reviews Materials (2023)
-
Cancer nanomedicine: emergence, expansion, and expectations
SN Applied Sciences (2023)
-
Too advanced for assessment? Advanced materials, nanomedicine and the environment
Environmental Sciences Europe (2022)